Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-07-07 | "Dr. Fardis received her Ph.D. in Organic Chemistry from the University of California Berkeley and her B.S. in chemistry..." |
| 2017-04-20 | “Dr. Fardis... worked at Pharmacyclics... Prior to joining Pharmacyclics, ... held increasingly senior positions in Medicinal Chemistry... Dr. Fardis received her Ph.D. in Organic Chemistry... and her B.S.... in chemistry...” |
| 2018-04-25 | "Dr. Fardis... held increasingly senior positions in Medicinal Chemistry and the project and portfolio management department... Dr. Fardis received her Ph.D. in Organic Chemistry... and her B.S.... in chemistry... Dr. Fardis holds an MBA..." |
| 2019-04-29 | "Dr. Fardis received her Ph.D. in Organic Chemistry... and her B.S. ... in chemistry..." |
| 2020-04-27 | "Dr. Fardis received her Ph.D. in Organic Chemistry... and her B.S. ... in chemistry... Dr. Fardis is highly qualified... because of her experience as an executive of multiple prior biopharmaceutical companies, extensive experience in drug development, and strong scientific background." |
| 2021-04-27 | "Dr. Fardis received her Ph.D. in Organic Chemistry from the University of California, Berkeley and her B.S. summa cum laude, in chemistry from the University of Illinois, Urbana-Champaign. Dr. Fardis holds an M.B.A., with highest honors, from Golden Gate University." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04